Koen Augustyns
Koen Augustyns
Full professor, Medicinal Chemistry, University of Antwerp
Geverifieerd e-mailadres voor uantwerpen.be - Homepage
Geciteerd door
Geciteerd door
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family
AM Lambeir, P Proost, C Durinx, G Bal, K Senten, K Augustyns, ...
Journal of Biological Chemistry 276 (32), 29839-29845, 2001
Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction
P Proost, S Struyf, D Schols, G Opdenakker, S Sozzani, P Allavena, ...
Journal of Biological Chemistry 274 (7), 3988-3993, 1999
Synthesis and evaluation of caffeic acid amides as antioxidants
P Rajan, I Vedernikova, P Cos, DV Berghe, K Augustyns, A Haemers
Bioorganic & Medicinal Chemistry Letters 11 (2), 215-217, 2001
In vitro antioxidant profile of phenolic acid derivatives
P Cos, P Rajan, I Vedernikova, M Calomme, L Pieters, AJ Vlietinck, ...
Free radical research 36 (6), 711-716, 2002
Structure− activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors
A Belyaev, X Zhang, K Augustyns, AM Lambeir, I De Meester, ...
Journal of medicinal chemistry 42 (6), 1041-1052, 1999
Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells
IMD Bastos, P Grellier, NF Martins, G Cadavid-Restrepo, ...
Biochemical Journal 388 (1), 29-38, 2005
Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases
P Van der Veken, K Senten, I Kertèsz, I De Meester, AM Lambeir, ...
Journal of medicinal chemistry 48 (6), 1768-1780, 2005
Natural substrates of dipeptidyl peptidase IV
I De Meester, C Durinx, G Bal, P Proost, S Struyf, F Goossens, ...
Cellular peptidases in immune functions and diseases 2, 67-87, 2002
Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents
K Augustyns, K Amssoms, A Yamani, PK Rajan, A Haemers
Current pharmaceutical design 7 (12), 1117, 2001
Development of irreversible diphenyl phosphonate inhibitors for urokinase plasminogen activator
J Joossens, P Van der Veken, AM Lambeir, K Augustyns, A Haemers
Journal of medicinal chemistry 47 (10), 2411-2413, 2004
Prolyl oligopeptidase stimulates the aggregation of α-synuclein
I Brandt, M Gérard, K Sergeant, B Devreese, V Baekelandt, K Augustyns, ...
Peptides 29 (9), 1472-1478, 2008
A new approach towards the synthesis of 3-amino-6-(hetero) arylpyridazines based on palladium catalyzed cross-coupling reactions
BUW Maes, GLF Lemiere, R Dommisse, K Augustyns, A Haemers
Tetrahedron 56 (12), 1777-1781, 2000
Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability
K Augustyns, F Vandendriessche, A Van Aerschot, R Busson, C Urbanke, ...
Nucleic acids research 20 (18), 4711-4716, 1992
The therapeutic potential of inhibitors of dipeptidyl peptidase IV (DPP IV) and related proline-specific dipeptidyl aminopeptidases
K Augustyns, PV d Veken, K Senten, A Haemers
Current medicinal chemistry 12 (8), 971-998, 2005
When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157
D Rojas-Rivera, T Delvaeye, R Roelandt, W Nerinckx, K Augustyns, ...
Cell Death & Differentiation 24 (6), 1100-1110, 2017
Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy?
M Berg, P Van der Veken, A Goeminne, A Haemers, K Augustyns
Current medicinal chemistry 17 (23), 2456-2481, 2010
Dipeptidyl peptidase IV inhibitors as new therapeutic agents for the treatment of Type 2 diabetes
K Augustyns, P Van der Veken, K Senten, A Haemers
Expert Opinion on Therapeutic Patents 13 (4), 499-510, 2003
Dipeptidyl peptidase 8/9‐like activity in human leukocytes
MB Maes, V Dubois, I Brandt, AM Lambeir, P Van der Veken, K Augustyns, ...
Journal of leukocyte biology 81 (5), 1252-1257, 2007
Diphenyl phosphonate inhibitors for the urokinase-type plasminogen activator: Optimization of the P4 position
J Joossens, P Van der Veken, G Surpateanu, AM Lambeir, I El-Sayed, ...
Journal of medicinal chemistry 49 (19), 5785-5793, 2006
Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP …
MB Maes, AM Lambeir, K Gilany, K Senten, P Van der Veken, B Leiting, ...
Biochemical Journal 386 (2), 315-324, 2005
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20